Silvercrest Asset Management Group »

Arrowhead Pharmaceuticals shares owned by Silvercrest Asset Management Group

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Silvercrest Asset Management Group from 13F filings

Historical chart of Silvercrest Asset Management Group investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Silvercrest Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Silvercrest Asset Management Group

Quarter filed Position value Share count Share price at filing
2023-09-30 $2.7M 100k 26.87
2023-06-30 $3.6M 100k 35.66
2023-03-31 $2.2M 86k 25.40

More positions owned by Silvercrest Asset Management Group

Microsoft Corporation (MSFT)
Matador Resources (MTDR)
Broadcom (AVGO)
Alphabet Inc Class C cs (GOOG)
Oracle Corporation (ORCL)
Apple (AAPL)
Cadence Bank (CADE)
Abbott Laboratories (ABT)
Cisco Systems (CSCO)
Chevron Corporation (CVX)
Home Depot (HD)
Ameriprise Financial (AMP)
ICF International (ICFI)
Microchip Technology (MCHP)
Humana (HUM)

View all positions for Silvercrest Asset Management Group

Top funds holding Arrowhead Pharmaceuticals

Vanguard Group
Jpmorgan Chase & Co
Credit Suisse
Norges Bank Investment Management
Rokos Capital Management
Artal Group
venBio Select Advisor
Goldman Sachs Group
Bank of New York Mellon
Ubs Global Asset Management Americas
Aquilo Capital Management
Charles Schwab Investment Management
Western Financial Corp
Avidity Partners Management
E. Ohman J:or Asset Management AB

View all funds holding Arrowhead Pharmaceuticals